Back to Archived Journals » Core Evidence » Volume 15
Core Evidence ceased publishing in March 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 15, 2020

Riociguat in the Treatment of Chronic Thromboembolic Pulmonary Hypertension: An Evidence-Based Review of Its Place in Therapy
Donaldson S, Ogunti R, Kibreab A, Mehari A
Core Evidence 2020, 15:31-40
Published Date: 25 August 2020

Management of Chemotherapy-Induced Nausea and Vomiting (CINV): A Short Review on the Role of Netupitant-Palonosetron (NEPA)
Lorusso V, Russo A, Giotta F, Codega P
Core Evidence 2020, 15:21-29
Published Date: 27 July 2020

Vedolizumab in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Safety, Efficacy, and Place of Therapy
Takatsu N, Hisabe T, Higashi D, Ueki T, Matsui T
Core Evidence 2020, 15:7-20
Published Date: 1 April 2020

Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation
Seeger J, Wöhrle J
Core Evidence 2020, 15:1-6
Published Date: 21 January 2020